Onderneming Neos Therapeutics, Inc.
Aandelen
NEOS
US64052L1061
Farmaceutische producten
Vakgebied
Aantal werknemers: 213
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 27-06-18 | |
Mark Oki
DFI | Director of Finance/CFO | 55 | - |
Margaret Cabano
COO | Chief Operating Officer | - | 01-01-05 |
Greg Pyszczymuka
PRN | Corporate Officer/Principal | - | 01-11-18 |
Carolyn R. Sikes
PRN | Corporate Officer/Principal | - | - |
Steven M. Lutz
SAM | Sales & Marketing | 57 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 27-06-18 | |
Bryant Fong
BRD | Director/Board Member | 51 | 15-06-09 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 49 792 123 | 49 223 944 ( 98,86 %) | 33 801 ( 0,0679 %) | 98,86 % |
Bedrijfsgegevens
Neos Therapeutics, Inc.
2940 North State Highway 360 Suite 360
75050-6424, Grand Prairie
+972 408 1300
http://www.neostx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |